Felicia Skelton-Dudley1,2, James Doan2, Katie Suda3,4, S Ann Holmes2, Charlesnika Evans3,5, Barbara Trautner1,6. 1. Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, Texas. 2. H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas. 3. Center for Innovation for Complex Chronic HealthCare (CINCCH), Edward Hines Jr. VA Hospital, Chicago, Illinois. 4. University of Illinois at Chicago, Chicago, Illinois. 5. Northwestern University, Department of Preventive Medicine and Center for Health Care Studies, Institute for Public Health and Medicine, Feinberg School of Medicine, Chicago, Illinois. 6. Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Abstract
Background: Catheter-associated urinary tract infection (CAUTI) is associated with increased morbidity and mortality and influences the quality of life of patients with spinal cord injury (SCI). Objectives: This clinical review aims to highlight the unique surveillance, prevention, diagnosis, and management challenges of CAUTI in the SCI population. Methods: Narrative review of the current literature on catheter use in persons with SCI was conducted to determine gaps in knowledge and opportunities for improvement. Results: Surveillance of CAUTI is challenging in the SCI population as the ability to detect symptoms used to diagnose CAUTI (ie, suprapubic pain, dysuria) is impaired. In terms of prevention of CAUTI, current strategies refocus on appropriate catheter insertion and care and early removal of catheters, which is not always feasible for persons with SCI. Prophylactic antibiotics, nutraceuticals, and coated catheters show limited efficacy in infection prevention. Diagnosing CAUTI after SCI is challenging, often resulting in an overdiagnosis of CAUTI when truly asymptomatic bacteriuria exists. In the management of CAUTI in patients with SCI, the use of multiple antibiotics over time in an individual increases the rate of multidrug-resistant organisms; therefore, the exploration of novel non-antibiotic treatments is of importance. The patient experience should be at the center of all these efforts. Conclusion: Better diagnostic tools or biomarkers are needed to define true CAUTI in people with SCI. SCI-specific evidence to inform catheter management and CAUTI treatment guidelines is needed, with the goal to minimize catheter-related harm, reduce antibiotic resistance, and improve satisfaction and overall quality of life for SCI patients.
Background: Catheter-associated urinary tract infection (CAUTI) is associated with increased morbidity and mortality and influences the quality of life of patients with spinal cord injury (SCI). Objectives: This clinical review aims to highlight the unique surveillance, prevention, diagnosis, and management challenges of CAUTI in the SCI population. Methods: Narrative review of the current literature on catheter use in persons with SCI was conducted to determine gaps in knowledge and opportunities for improvement. Results: Surveillance of CAUTI is challenging in the SCI population as the ability to detect symptoms used to diagnose CAUTI (ie, suprapubic pain, dysuria) is impaired. In terms of prevention of CAUTI, current strategies refocus on appropriate catheter insertion and care and early removal of catheters, which is not always feasible for persons with SCI. Prophylactic antibiotics, nutraceuticals, and coated catheters show limited efficacy in infection prevention. Diagnosing CAUTI after SCI is challenging, often resulting in an overdiagnosis of CAUTI when truly asymptomatic bacteriuria exists. In the management of CAUTI in patients with SCI, the use of multiple antibiotics over time in an individual increases the rate of multidrug-resistant organisms; therefore, the exploration of novel non-antibiotic treatments is of importance. The patient experience should be at the center of all these efforts. Conclusion: Better diagnostic tools or biomarkers are needed to define true CAUTI in people with SCI. SCI-specific evidence to inform catheter management and CAUTI treatment guidelines is needed, with the goal to minimize catheter-related harm, reduce antibiotic resistance, and improve satisfaction and overall quality of life for SCIpatients.
Authors: Lindsay E Nicolle; Suzanne Bradley; Richard Colgan; James C Rice; Anthony Schaeffer; Thomas M Hooton Journal: Clin Infect Dis Date: 2005-02-04 Impact factor: 9.079
Authors: Saima Aslam; Victor Pretorius; Susan M Lehman; Sandra Morales; Robert T Schooley Journal: J Heart Lung Transplant Date: 2019-01-07 Impact factor: 10.247
Authors: Lindsay E Nicolle; Kalpana Gupta; Suzanne F Bradley; Richard Colgan; Gregory P DeMuri; Dimitri Drekonja; Linda O Eckert; Suzanne E Geerlings; Béla Köves; Thomas M Hooton; Manisha Juthani-Mehta; Shandra L Knight; Sanjay Saint; Anthony J Schaeffer; Barbara Trautner; Bjorn Wullt; Reed Siemieniuk Journal: Clin Infect Dis Date: 2019-05-02 Impact factor: 9.079
Authors: Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: Barbara W Trautner; Larissa Grigoryan; Nancy J Petersen; Sylvia Hysong; Jose Cadena; Jan E Patterson; Aanand D Naik Journal: JAMA Intern Med Date: 2015-07 Impact factor: 21.873
Authors: Felicia Skelton; Sarah May; Larissa Grigoryan; Ivy Poon; Sally Ann Holmes; Lindsey Martin; Barbara W Trautner Journal: PM R Date: 2020-05-13 Impact factor: 2.298
Authors: Belkys C Sanchez; Emmaline R Heckmann; Sabrina I Green; Justin R Clark; Heidi B Kaplan; Robert F Ramig; Casey Hines-Munson; Felicia Skelton; Barbara W Trautner; Anthony W Maresso Journal: Front Microbiol Date: 2022-05-10 Impact factor: 6.064
Authors: Casey Hines-Munson; Sarah May; Ivy Poon; S Ann Holmes; Lindsey Martin; Barbara W Trautner; Felicia Skelton Journal: PM R Date: 2021-07-22 Impact factor: 2.298
Authors: Kimberly C Claeys; Min Zhan; Lisa Pineles; Alison Lydecker; Gosia Clore; Michihiko Goto; Surbhi Leekha; Darren Linkin; Charlesnika T Evans; Barbara W Trautner; Matthew B Goetz; Jonathan D Baghdadi; Eli N Perencevich; Daniel J Morgan Journal: Infect Control Hosp Epidemiol Date: 2020-08-25 Impact factor: 3.254